Recent evidence suggests that soluble extracellular aggregates of tau play a role in the molecular pathogenesis of tauopathies, including Alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE). Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.